Which has grown faster, BTMD or RANI?

Over the past five years, BTMD grew revenue faster — BTMD at a 10.52% CAGR versus RANI at 9.95%.

Is BTMD or RANI more profitable?

BTMD runs the higher net margin — BTMD at 3.19% versus RANI at -618.02%.

How have BTMD and RANI total returns compared?

Over the past 5 years, BTMD delivered -35.12% and RANI delivered -46.70% annualized total return. Past performance doesn't predict future results.

biote Corp. (BTMD) vs Rani Therapeutics Holdings, Inc. (RANI)

A side-by-side comparison of biote Corp. and Rani Therapeutics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BTMD

biote Corp.

$52M

$1.18HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

RANI

Rani Therapeutics Holdings, Inc.

$52M

$0.80HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT

Total return — BTMD vs RANI

growth of $100 · dividends reinvested · last 5y

BTMD -88.4% (-35.0%/yr)RANI -93.0% (-41.2%/yr)BTMD compounded faster over this window

BTMD RANI

BTMD vs RANI: by the numbers

•RANI is the larger company ($52M vs $52M market cap).
•BTMD is profitable (3.19% net margin) while RANI runs a net loss (-618.02%).
•BTMD grew revenue faster over the past five years (10.52% vs 9.95% CAGR).

Metrics side by side

Valuation

Metric	BTMD	RANI
P/E ratio	10.11	N/A
P/S ratio	0.28	10.74
P/B ratio	N/A	1.34
EV / EBITDA	9.11	N/A
FCF yield	37.81%	N/A

Profitability

Metric	BTMD	RANI
Gross margin	71.46%	44.89%
Operating margin	18.50%	-2345.99%
Net margin	3.19%	-618.02%
ROE	N/A	-76.82%
ROIC	13.63%	-63.96%

Growth (annualized)

Metric	BTMD	RANI
Revenue CAGR (5Y)	10.52%	9.95%
EPS CAGR (5Y)	-25.90%	N/A
FCF CAGR (5Y)	3.81%	N/A
Total return CAGR (5Y)	-35.12%	-46.70%

Frequently asked

Which has grown faster, BTMD or RANI?: Over the past five years, BTMD grew revenue faster — BTMD at a 10.52% CAGR versus RANI at 9.95%.
Is BTMD or RANI more profitable?: BTMD runs the higher net margin — BTMD at 3.19% versus RANI at -618.02%.
How have BTMD and RANI total returns compared?: Over the past 5 years, BTMD delivered -35.12% and RANI delivered -46.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BTMD analysis Full RANI analysis Interactive comparison tool

Dig into the metrics

biote P/E ratio biote ROE Rani Therapeutics ROE biote operating margin Rani Therapeutics operating margin biote revenue growth Rani Therapeutics revenue growth biote free cash flow Rani Therapeutics free cash flow

biote & Rani Therapeutics appear in these rankings

Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.